Skip to main content

Table 1 Concentrations of cyclophosphamide and fluorouracil in wipe samples from APOTECAchemo and biological safety cabinet locations

From: Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital

 

Place

Sampling timing

FU (ng/cm2)

CPA (ng/cm2)

APOTECA chemo (Robotics)

Loading area

Before compounding

nd

nd

After compounding

nd

nd

Compounding area, under shelf

Before compounding

After compounding

nd

nd

nd

nd

Compounding area, under dosing device

Before compounding

After compounding

nd

nd

Nd

25

Scale balance

Before compounding

nd

nd

After compounding

nd

nd

Gripper of robot arm

Before compounding

nd

nd

After compounding

nd

0.04

Gloves 1st

After FU compounding

nd

-

Gloves 2nd

After compounding

nd

nd

Bag 1

After compounding

nd

nd

Bag 2

After compounding

nd

nd

Bag 3

After compounding

nd

nd

Bag 4

After compounding

nd

nd

BSC (Manual)

Inside BSC

Before compounding

nd

nd

After compounding

12.5

nd

Gloves 1st

After FU compounding

nd

-

Gloves 2nd

After compounding

nd

nd

Bag 1

After compounding

nd

nd

Bag 2

After compounding

nd

nd

Bag 3

After compounding

0.15

nd

Bag 4

After compounding

1.03

nd

  1. FU Fluorouracil, CPA Cyclophosphamide, BSC biological safety cabinet
  2. nd means < 0.05 ng/cm2 for Fluorouracil; < 0.02 ng/cm2 for Cyclophosphamide